Arcellx (ACLX) Cash & Equivalents (2021 - 2025)

Arcellx's quarterly Cash & Equivalents came in at $80.3 million in Q4 2025, down 24.05% year-on-year from $105.7 million in Q4 2024, and up 1.59% quarter-over-quarter from $79.0 million in Q3 2025.

Arcellx has reported Cash & Equivalents for 5 years, with the latest figure at $80.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 24.05% year-over-year to $80.3 million; the trailing twelve-month figure through Dec 2025 stood at $80.3 million (down 24.05% YoY), and the FY2025 full-year result was $80.3 million, down 24.05% from the prior year.
  • Cash & Equivalents for Q4 2025 stood at $80.3 million, up from $79.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $394.6 million in Q4 2023, with the low at $30.8 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $134.9 million, with a median of $111.7 million recorded in 2021.
  • Year-over-year, Cash & Equivalents soared 514.82% in 2023 and plunged 73.22% in 2024.
  • Tracing ACLX's Cash & Equivalents over 5 years: stood at $30.8 million in 2021, then surged by 108.15% to $64.2 million in 2022, then soared by 514.82% to $394.6 million in 2023, then sank by 73.22% to $105.7 million in 2024, then decreased by 24.05% to $80.3 million in 2025.
  • The last three Cash & Equivalents figures came in at $80.3 million (Q4 2025), $79.0 million (Q3 2025), and $62.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 80.26 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 80.26 Mn
Sep 30, 2025 79.01 Mn
Jun 30, 2025 62.34 Mn
Mar 31, 2025 80.86 Mn
Dec 31, 2024 105.68 Mn
Sep 30, 2024 161.85 Mn
Jun 30, 2024 100.03 Mn
Mar 31, 2024 154.57 Mn
Dec 31, 2023 394.58 Mn
Sep 30, 2023 126.12 Mn
Jun 30, 2023 303.67 Mn
Mar 31, 2023 274.89 Mn
Dec 31, 2022 64.18 Mn
Sep 30, 2022 56.76 Mn
Jun 30, 2022 164.54 Mn
Mar 31, 2022 127.16 Mn
Dec 31, 2021 30.83 Mn
Sep 30, 2021 70.03 Mn
Jun 30, 2021 143.79 Mn
Mar 31, 2021 117.65 Mn